Conference abstractPublished 27 Mar 2023
A network-based approach for drug-repurposing along with its application to sarscovs infection and neurodegeneative diseases
Sapienza University of Rome, Italy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Drug repositioning (or drug repurposing) represents an effective drug discovery strategy to find new uses from existing drugs out of the scope of their original medical indication, which could shorten the time and reduce the cost compared to de novo drug discovery [1]. In this context, we developed a new network-based algorithm for drug repurposing called SAveRUNNER (Searching off-lAbel dRUg aNd NEtwoRk), with the aim to offer a promising framework to efficiently detect putative novel indications for currently marketed drugs against diseases of interest [2,3]. SAveRUNNER predicts drug-disease associations by quantifying the interplay between the drug targets and the disease-associated proteins in the human interactome through the computation of a novel networkbased similarity measure, which prioritizes associations between drugs and diseases located in the same network neighborhoods. SAveRUNNER was successfully applied to predict off-label drugs to be repositioned against the new human coronavirus (2019-nCoV/SARS-CoV-2), and it achieved high accuracy in the identification of well-known drug indications, thus revealing itself as a powerful tool to rapidly detect potential novel medical indications for various drugs that are worthy of further investigation. More recently, it has been successfully applied to identify candidate repurposable drugs for neurodegenerative diseases such as Amyotrophic lateral sclerosis (ALS) [4] and Multiple Sclerosis (MS) [5]. By prioritizing the networkpredicted drugs according to the decreasing value of their network similarity with ALS and MS, SAveRUNNER highlighted some interesting drugs related to histamine pathways, worthy of further investigation.
Subjects
ChemistryPharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMedicinal Chemistry
- SubjectChemistry
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Giulia Fiscon”
